A new study shows that Johnson & Johnson‘s prostate cancer pill Zytiga dramatically slows the progression of the disease in men who are not yet sick enough to start chemotherapy. More...
A new study shows that Johnson & Johnson‘s prostate cancer pill Zytiga dramatically slows the progression of the disease in men who are not yet sick enough to start chemotherapy. More...
Posted by D. Shahwan at 12:16:00 PM
| | Home | About Us | Candidate Services | Clients | Expertise | Job Center | Submit Resume | Contact Us | |
| • Odin Search Group, an MRINetwork affiliate. • All Rights Reserved. |
||